Develo
About Develo
Develo is a digital-health startup. The company reached Series A stage in undefined with a null round led by Blueprint Equity. Develo's investor base includes 5 institutional funds, with Blueprint Equity leading the most recent equity round.
Develo is a Los Angeles-based health tech startup building an AI-native operating system purpose-built for independent pediatric practices. The platform unifies EMR/EHR, billing and revenue cycle management, and family engagement into a single subscription, replacing the patchwork of legacy tools that drive physician burnout and administrative burden. Co-founded in 2022 by pediatrician-researcher Aaron Sin (CEO, formerly McKinsey and Innovaccer) and engineer Han Ke (CTO, formerly Wellsheet), Develo serves hundreds of pediatric providers across 25+ US states and raised a $14M round led by Blueprint Equity in May 2026.
Develo Funding Rounds Timeline
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Undisclosed | — | Blueprint Equity | Villain Capital, Z21 Ventures, Bienville Capital | ||
| Undisclosed | — | Z21 Ventures | Fractal Software | ||
| Undisclosed | — | — | — |
Investors in Develo
5 institutional investors
Lead investors
Co-investors
Questions about Develo
How much has Develo raised?
Develo has raised null across undefined funding rounds since undefined.
Who are the investors of Develo?
Develo's investors include Blueprint Equity, Z21 Ventures, Villain Capital, Bienville Capital, Fractal Software.
When was Develo's last funding round?
Develo's most recent round was a null undefined in undefined, led by Blueprint Equity.